Inactive Instrument

Press Releases ZS Pharma Inc

Equities

US98979G1058

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2016	AstraZeneca : potassium drug delayed by manufacturing snag	RE
2015	AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug	RE

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ZS Pharma : AstraZeneca completes acquisition of ZS Pharma	22/12/15	PU
ZS Pharma Announces New Employment Inducement Grants	09/12/15	GL
ZS Pharma : Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	12/11/15	BU
ZS PHARMA : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with AstraZeneca PLC	11/11/15	BU
ZS Pharma Announces New Employment Inducement Grants	10/11/15	GL
ZS Pharma : Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Investors To Contact The Firm For Additional Information	10/11/15	BU
ZS Pharma Announces Positive Interim Results From a Long-Term Safety Study of ZS-9	07/11/15	GL
ZS Pharma Announces Upcoming Poster Presentation of Interim Results From Its Long-Term Safety Study of ZS-9	19/10/15	GL
ZS Pharma Corporate Statement	10/09/15	GL
ZS Pharma Reports Second Quarter 2015 Financial Results and Provides Corporate Update	06/08/15	GL
ZS Pharma Announces FDA Acceptance of ZS-9 New Drug Application	29/07/15	GL
ZS Pharma Announces Participation at Upcoming Investor Conferences	28/05/15	GL
ZS Pharma Submits New Drug Application to U.S. Food and Drug Administration for ZS-9 for the Treatment of Hyperkalemia	26/05/15	GL
ZS Pharma Reports First Quarter 2015 Financial Results and Provides ZS-9 Program Update	11/05/15	GL
ZS Pharma Announces Publications in Peer-Reviewed Medical Journals	15/04/15	GL
ZS Pharma Announces Upsizing and Pricing of $186 Million Public Offering of Common Stock	25/03/15	GL
ZS Pharma Announces Proposed Public Offering of Common Stock	23/03/15	GL
ZS Pharma Reports Fourth Quarter and Year-End 2014 Financial Results and Provides ZS-9 Program Update	13/03/15	GL
ZS Pharma Hires Key Medical Affairs and Commercial Executives	19/02/15	GL
ZS Pharma Appoints Martin Babler to Board of Directors	10/02/15	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ZS Pharma Inc

Equities

US98979G1058

Press Releases

Filters